<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care Sci</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care Sci</journal-id><journal-id journal-id-type="publisher-id">ccsci</journal-id><journal-title-group><journal-title>Critical Care Science</journal-title></journal-title-group><issn pub-type="epub">2965-2774</issn><publisher><publisher-name>Associa&#x000e7;&#x000e3;o de Medicina Intensiva Brasileira - AMIB</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12094690</article-id><article-id pub-id-type="other">00315</article-id><article-id pub-id-type="doi">10.62675/2965-2774.20250229</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Frailty influences clinical outcomes in critical patients: a post hoc analysis of the PalMuSIC study</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2965-9899</contrib-id><name><surname>Mestre</surname><given-names>Ana</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c1" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0005-6666-4349</contrib-id><name><surname>Afonso</surname><given-names>Rodrigo</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6714-8585</contrib-id><name><surname>Ferreira-Sim&#x000f5;es</surname><given-names>Andr&#x000e9;</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2082-0634</contrib-id><name><surname>Correia</surname><given-names>Iuri</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7538-3777</contrib-id><name><surname>Pereira</surname><given-names>Jo&#x000e3;o Gon&#x000e7;alves</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><aff id="aff1">
<label>1</label>
<institution content-type="orgname">Hospital Vila Franca de Xira</institution>
<institution content-type="orgdiv1">Intensive Care Unit</institution>
<addr-line>
<named-content content-type="city">Vila Franca de Xira</named-content>
</addr-line>
<country country="PT">Portugal</country>
<institution content-type="original">Intensive Care Unit, Hospital Vila Franca de Xira - Vila Franca de Xira, Portugal.</institution>
</aff><aff id="aff2">
<label>2</label>
<institution content-type="orgname">Universidade de Lisboa</institution>
<institution content-type="orgdiv1">Faculdade de Medicina</institution>
<addr-line>
<named-content content-type="city">Lisboa</named-content>
</addr-line>
<country country="PT">Portugal</country>
<institution content-type="original">Faculdade de Medicina, Universidade de Lisboa - Lisboa, Portugal.</institution>
</aff><aff id="aff3">
<label>3</label>
<institution content-type="orgname">Hospital CUF Tejo</institution>
<institution content-type="orgdiv1">Palliative Care Unit</institution>
<addr-line>
<named-content content-type="city">Lisboa</named-content>
</addr-line>
<country country="PT">Portugal</country>
<institution content-type="original">Palliative Care Unit, Hospital CUF Tejo - Lisboa, Portugal.</institution>
</aff></contrib-group><author-notes><corresp id="c1">
<label>Corresponding author:</label> Ana Mestre Intensive Care Unit Hospital Vila Franca de Xira Estrada Carlos Lima Costa, n&#x000ba;2, <postal-code>2600-009</postal-code> Vila Franca de Xira, Portugal E-mail: <email>anamartinsmestre@gmail.com</email>
</corresp><fn fn-type="COI-statement"><p><bold>Conflicts of interest:</bold> None.</p></fn><fn fn-type="edited-by"><p><bold>Responsible editor:</bold> Alexandre Biasi Cavalcanti <ext-link xlink:href="https://orcid.org/0000-0003-2798-6263" ext-link-type="uri">https://orcid.org/0000-0003-2798-6263</ext-link>
</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>37</volume><elocation-id>e20250229</elocation-id><history><date date-type="received"><day>15</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2024</year></date></history><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><title>ABSTRACT</title><sec><title>Objective:</title><p>Frailty is a multidimensional syndrome characterized by diminished physiological reserve, increasing the risk of adverse outcomes, particularly in intensive care unit patients. The Clinical Frailty Scale, ranging from 1 (nonfrail) to 9 (terminally ill), is widely used to quantify frailty. This post hoc analysis of the Palliative Multicenter Study in Intensive Care (PalMuSIC) assesses the impact of frailty and clinical severity on short- and long-term outcomes.</p></sec><sec><title>Methods:</title><p>This subanalysis involved 23 Portuguese intensive care units and 335 patients. Patients admitted between March 1 and May 15, 2019, aged &#x02265; 18 years, and hospitalized for &#x0003e; 24 hours in the intensive care unit were eligible. The severity of illness was assessed using SAPS II, and frailty was assessed using the clinical frailty scale, which was recorded by a nurse and a doctor in charge. Patients were classified as frail (clinical frailty scale score &#x02265; 5), prefrail (clinical frailty scale score = 4), or nonfrail (clinical frailty scale score &#x0003c; 4). The outcomes measured included intensive care unit and hospital LOS (length of stay), need for organ support, infections, mortality at hospital discharge and mortality at 6 months post discharge. We divided the population in half according to the length of their intensive care unit stay to evaluate a possible interaction between intensive care unit length of stay and frailty.</p></sec><sec><title>Results:</title><p>The mean age was 63.2 years, and 66% were male. The mean SAPS II score was 41.8. Frailty was observed in 23.0% of the patients. Frail patients had higher hospital mortality (39.0% frail patients <italic toggle="yes">versus</italic> 28.2% prefrail patients <italic toggle="yes">versus</italic> 11.8% nonfrail patients) and 6-month mortality (frail 49.4% frail patients <italic toggle="yes">versus</italic> 30.6% prefrail patients <italic toggle="yes">versus</italic> 15.6% nonfrail patients). Patients with longer intensive care unit stays had higher 6-month mortality rates than did those with shorter intensive care unit stays did, which resulted in more frail patients: odds ratio (95% confidence interval) 3.1 (1.2 - 7.8) <italic toggle="yes">versus</italic> odds ratio 1.8 (0.9 - 4.0) in nonfrail patients.</p></sec><sec><title>Conclusion:</title><p>Frailty may significantly impact hospital and 6-month mortality. In our cohort, a longer intensive care unit length of stay was associated with worse long-term outcomes, especially in frail patients.</p></sec></abstract><kwd-group><title>Keywords:</title><kwd>Frailty</kwd><kwd>Frail elderly</kwd><kwd>Clinical frailty scale</kwd><kwd>Mortality</kwd><kwd>Critical care outcomes</kwd><kwd>Length of stay</kwd><kwd>Intensive care units</kwd></kwd-group><counts><fig-count count="1"/><table-count count="4"/><equation-count count="0"/><ref-count count="20"/></counts></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Frailty is a complex and multidimensional syndrome characterized by diminished physiological reserve, increasing the risk of poor outcomes for patients.<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup> It is a condition of vulnerability that reduces the ability to adapt to an external insult or recover after acute illness. The size of the senior population is increasing worldwide, making frailty an increasing concern for healthcare systems. Although frailty is more prevalent in elderly individuals, it is not invariably associated with age and exists among all age groups. Frailty is common in patients admitted to the intensive care unit (ICU), and it is associated with worse outcomes.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup></p><p>The Clinical Frailty Scale (CFS) is widely used in the ICU population to quantify frailty. It is a clinical judgment-based assessment tool consisting of a rating scale designed to assess frailty according to physical activity, functional status, chronic illness burden, and cognition. This score uses a scale that ranges from 1 to 9. Scores of 1 to 3 are considered nonfrail; a score of 4 is considered prefrail or vulnerable; scores of 5 to 8 are deemed frail; and a score of 9 indicates terminal illness.<sup>(<xref rid="B3" ref-type="bibr">3</xref>)</sup> The prevalence of frailty in critically ill patients may be as high as 35%,<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> dependent on the type of ICU. Frailty assessed by the CFS is strongly correlated with adverse outcomes.<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B5" ref-type="bibr">5</xref>)</sup> Preadmission frailty has been identified as a relevant risk factor in critically ill patients for ICU- and hospital-related mortality, as well as for prolonged ICU hospitalization.<sup>(<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B6" ref-type="bibr">6</xref>)</sup></p><p>Clinical severity scores are largely available in the ICU setting and allow the evaluation of different populations&#x02019; severity and death probability as surrogates of the quality of care for benchmarketing purposes. Scoring systems, such as the commonly used Simplified Acute Physiology Score (SAPS) II, help to describe ICU populations and interpret outcome measures. The interactions among frailty, severity scores and outcomes are poorly understood.</p><p>This study is a post hoc analysis of a multicenter, prospective, observational study, the PALliative MUlticenter Study in Intensive Care (PalMuSIC).<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> We aimed to assess the impact of the interaction between frailty and clinical severity on short- and long-term outcomes. We also wanted to address whether a prolonged ICU length of stay (LOS) may worsen the outcomes of the frail population due to their lower physiological reserve.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This is a subanalysis of the PalMuSIC study. The study protocol has been published elsewhere.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> Briefly, PalMuSIC was a prospective, observational, multicenter study carried out to evaluate the prevalence of frailty in Portuguese ICUs and the use and adequacy of palliative care and invasive interventions.</p><p>The study was conducted in 23 Portuguese ICUs and included 335 patients. All patients admitted during a 15-day consecutive period, starting between 1st March and May 2019, aged &#x02265; 18 years and hospitalized for &#x0003e; 24 hours in the ICU, were considered eligible for inclusion. Written informed consent was obtained from all patients or their representatives.</p><p>The severity of illness at admission was assessed according to SAPS II, and frailty was assessed using the CFS. The CFS was independently recorded by the nurse and the doctor in charge. According to the average of these two assessments, all patients were classified as frail (CFS &#x02265; 5), prefrail (CFS = 4), or nonfrail (CFS &#x0003c; 4). We also asked the family member with the closest relationship to the patient to provide an assessment of the CFS. The ICU and hospital LOSs were calculated, along with the need for organ support (noninvasive or invasive mechanical ventilation, renal replacement therapy, or vasopressors). Infection upon admission or acquired in the ICU was also recorded. Mortality was evaluated at discharge from the hospital and at 6 months after discharge.</p><sec><title>Outcomes</title><p>We developed a multivariable model to identify risk factors independently associated with hospital mortality and 6-month all-cause mortality. To assess the interaction between a prolonged ICU LOS and frailty, we further divided our population into short and long ICU LOSs according to the median ICU LOS (5 days).</p></sec><sec><title>Statistics</title><p>The data are summarized as the means &#x000b1; standard deviations or medians [25 - 75% interquartile ranges (IQRs)] according to the data distribution. Categorical variables are described as N (%). The chi-square test was used to compare categorical variables, while continuous variables were evaluated with Student's <italic toggle="yes">t</italic> test or the Kruskal&#x02014;Wallis test, according to the data distribution. Multiple comparisons of variance were assessed with ANOVAs. Odds ratios (ORs) with 95% confidence intervals (95%CIs) were computed. We developed a multivariable model that included comorbidities, the SAPS II score, frailty status and ICU LOS to assess factors independently associated with hospital mortality and 6-month all-cause mortality. The univariate associations of clinically significant variables were assessed for model development. To ensure the inclusion of all clinically significant variables in the model, a p value as high as 0.2 was used for selection. Moreover, if an excluded variable was considered to have a possible influence on the outcome, it was also included in the model. Correlations between all included variables were checked. We arbitrarily used r &#x0003c; 0.3 as a low enough threshold to decrease the risk of significant multicollinearity. For variables that were correlated, the one that was considered more likely to be related to the outcome was selected. Model fit was assessed with the Hosmer&#x02014;Lemeshow goodness-of-fit test. Statistical analysis was performed using IBM SPSS Statistics v.29.0 (IBM, Somers, NY, USA). All statistics were 2-tailed, and the significance level was p &#x0003c; 0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Demographics</title><p>A total of 335 patients were included. The mean age was 63.2 &#x000b1; 16.8 years, and 66% were male. The mean SAPS II value was 41.8 &#x000b1; 17.4. The general characteristics of the patients are shown in <xref rid="t1" ref-type="table">table 1</xref>.</p><table-wrap position="float" id="t1"><label>Table 1</label><caption><title>Demographic and general characteristics of the population</title></caption><table frame="hsides" rules="groups"><colgroup width="17%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr style="background-color:#8FAAD8;"><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">Total</th><th align="center" valign="middle" rowspan="1" colspan="1">Frail</th><th align="center" valign="middle" rowspan="1" colspan="1">Prefrail</th><th align="center" valign="middle" rowspan="1" colspan="1">Nonfrail</th><th align="center" valign="middle" rowspan="1" colspan="1">p value<xref rid="TFN2" ref-type="table-fn">*</xref>
</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Patients</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">335</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">77 (23.0)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">85 (25.4)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">173 (51.6)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">221 (66.0)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">52 (67.5)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">49 (57.6)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">120 (69.4)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.166</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">63.2 &#x000b1; 16.8</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">71.5 &#x000b1; 12.8</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">68.4 &#x000b1; 13.1</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">56.9 &#x000b1; 17.5</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref>
</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">ICU LOS</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">5 [7]</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">5 [8]</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">5 [6.5]</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">6 [9.5]</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.765<xref rid="TFN4" ref-type="table-fn">&#x02021;</xref>
</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">SAPS II</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">41.8 &#x000b1; 17.4</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">50.0 &#x000b1; 17.4</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">45.7 &#x000b1; 16.0</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">36.3 &#x000b1; 16.1</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref>
</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Infection</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">201 (60)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">46 (59.7)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">48 (56.5)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">107 (61.8)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.731</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">IMV</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">214 (63.9)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">50 (64.9)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">59 (69.4)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">105 (60.7)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.382</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">NIV</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">57 (17.0)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">15 (19.5)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">20 (23.5)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">22 (12.7)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.076</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">RRT</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">48 (14.3)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">17 (22.1)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">15 (17.6)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">16 (9.2)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Vasopressors</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">185 (55.2)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">48 (62.3)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">50 (58.8)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">87 (50.3)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.155</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Previous hospital admission (3 months)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">75 (22.4)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">27 (35.1)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">18 (21.2)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">30 (17.3)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Hospital readmission (6 months)<xref rid="TFN5" ref-type="table-fn">&#x000a7;</xref>
</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">74 (28.9)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">22 (46.8)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">22 (36.1)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">30 (20.3)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ICU - intensive care unit; LOS - length of stay; SAPS - Simplified Acute Physiology Score; IMV - invasive mechanical ventilation; NIV - noninvasive ventilation RRT - renal replacement therapy.</p></fn><fn id="TFN2"><label>*</label><p>Chi-square test except</p></fn><fn id="TFN3"><label>&#x02020;</label><p>ANOVA with Fisher's variance method and</p></fn><fn id="TFN4"><label>&#x02021;</label><p>Kruskal-Wallis test;</p></fn><fn id="TFN5"><label>&#x000a7;</label><p>Patients discharged alive from the hospital only. Data are presented as the n (%), mean &#x000b1; standard deviation or median [interquartile range] according to the data distribution.</p></fn></table-wrap-foot></table-wrap><p>Frailty was observed in 23.0% of patients. Frail, prefrail, and nonfrail patients were significantly different in terms of age and SAPS II score (<xref rid="t1" ref-type="table">Table 1</xref>).</p></sec><sec><title>Mortality and standardized mortality ratio</title><p>Frail patients had higher in-hospital mortality rates (39.0% <italic toggle="yes">versus</italic> 28.2% <italic toggle="yes">versus</italic> 11.8%; p &#x0003c; 0.001). All-cause mortality after 6 months of follow-up was also significantly greater in frail patients (49.4% <italic toggle="yes">versus</italic> 30.6% <italic toggle="yes">versus</italic> 15.6%, p &#x0003c; 0.001) (<xref rid="t2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="t2"><label>Table 2</label><caption><title>Hospital and 6-month mortality</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr style="background-color:#8FAAD8;"><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">N</th><th align="center" valign="middle" rowspan="1" colspan="1">Hospital mortality<xref rid="TFN7" ref-type="table-fn">*</xref>
</th><th align="center" valign="middle" rowspan="1" colspan="1">6-month mortality<xref rid="TFN7" ref-type="table-fn">*</xref>
</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Nonfrail</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">173</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">24 (11.8)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">34 (15.6)</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Prefrail</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">85</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">24 (28.2)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">26 (30.6)</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Frail</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">77</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">30 (39.0)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">38 (49.4)</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>Data are presented as n (%).</p></fn><fn id="TFN7"><label>*</label><p>Chi-square test, p &#x0003c; 0.001.</p></fn></table-wrap-foot></table-wrap><p>In addition, frail patients who survived until hospital discharge often needed hospital readmission in the first 6 months, and this number was significantly higher than that of nonfrail patients (<xref rid="t1" ref-type="table">Table 1</xref>).</p><p>In <xref rid="f1" ref-type="fig">figure 1</xref>, we present the standardized mortality ratio (with 95%CI), which was calculated as the ratio between the observed mortality and the SAPS II score-predicted mortality on admission to the ICU. Frailty seemed to impact the standardized mortality ratio, revealing the importance of the case mix on the outcomes.</p><fig position="float" id="f1"><label>Figure 1</label><caption><title>Standardized mortality ratios, with 95% confidence intervals, calculated at intensive care unit discharge, hospital discharge, and after 6 months of follow-up, revealing the potential influence of frailty on mortality.</title></caption><graphic xlink:href="2965-2774-ccsci-37-e20250229-gf01" position="float"/></fig></sec><sec><title>Relationship between mortality and time in the intensive care unit</title><p>We divided the studied population into two different groups according to the median ICU LOS (5 days): long ICU stay (n = 163, 40 frail) and short ICU stay (n = 172, 37 frail). Significant differences between the two groups were noted: in patients with shorter ICU LOSs, mortality was consistently lower in the hospital and after 6 months of follow-up (<xref rid="t3" ref-type="table">Table 3</xref>).</p><table-wrap position="float" id="t3"><label>Table 3</label><caption><title>Hospital and 6-month mortality according to intensive care unit length of stay</title></caption><table frame="hsides" rules="groups"><colgroup width="14%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr style="background-color:#8FAAD8;"><th align="left" rowspan="2" style="border-bottom: thin solid; border-color: #000000" valign="middle" colspan="1"/><th align="center" colspan="3" style="border-bottom: thin solid; border-color: #000000" valign="middle" rowspan="1">Hospital mortality</th><th align="center" colspan="3" style="border-bottom: thin solid; border-color: #000000" valign="middle" rowspan="1">6-month mortality</th></tr><tr style="background-color:#8FAAD8;"><th align="center" valign="middle" rowspan="1" colspan="1">Short stay (N = 172)</th><th align="center" valign="middle" rowspan="1" colspan="1">Long stay (N = 163)</th><th align="center" valign="middle" rowspan="1" colspan="1">OR (95%CI)</th><th align="center" valign="middle" rowspan="1" colspan="1">Short stay (N = 172)</th><th align="center" valign="middle" rowspan="1" colspan="1">Long stay (N = 163)</th><th align="center" valign="middle" rowspan="1" colspan="1">OR (95%CI)</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Nonfrail (N = 173)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">9 (10.3)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">12 (17.4)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">1.8 (0.8 - 4.4)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">13 (14.9)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">17 (24.4)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">1.8 (0.9 - 4.0)</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Prefrail (N = 85)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">10 (20.8)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">11 (37.8)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">2.3 (0.9 - 6.1)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">11 (22.9)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">12 (40.5)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">2.3 (0.9 - 5.8)</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Frail (N = 77)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">10 (27.0)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">20 (50.0)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">2.7 (1.0 - 7.0)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">13 (35.1)</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">25 (62.5)</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">3.1 (1.2 - 7.8)</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1"/><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">p<xref rid="TFN9" ref-type="table-fn">*</xref> = 0.052</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">p<xref rid="TFN9" ref-type="table-fn">*</xref> = 0.042</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1"/><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">p<xref rid="TFN9" ref-type="table-fn">*</xref> &#x0003c; 0.001</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">p<xref rid="TFN9" ref-type="table-fn">*</xref> &#x0003c; 0.001</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN8"><p>OR - odds ratio; 95%CI - 95% confidence interval.</p></fn><fn id="TFN9"><label>*</label><p>Chi-square test. Data presented as n (%).</p></fn></table-wrap-foot></table-wrap><p>However, this difference was more striking in frail patients (<xref rid="t3" ref-type="table">Table 3</xref>). The ORs for both hospital mortality and 6-month mortality increased from nonfrail to prefrail to frail patients.</p></sec><sec><title>Variables associated with mortality</title><p>Our multivariable models revealed that the SAPS II score was associated not only with in-hospital mortality but also with 6-month all-cause mortality. The only comorbidity also associated with mortality in our models was heart failure. Curiously, both frailty and ICU LOS were associated with 6-month mortality but not with hospital mortality (<xref rid="t4" ref-type="table">Table 4</xref>).</p><table-wrap position="float" id="t4"><label>Table 4</label><caption><title>Multivariable analysis for hospital mortality and 6-month all-cause mortality</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr style="background-color:#8FAAD8;"><th align="left" rowspan="2" style="border-bottom: thin solid; border-color: #000000" valign="middle" colspan="1"/><th align="center" colspan="2" style="border-bottom: thin solid; border-color: #000000" valign="middle" rowspan="1">Hospital mortality</th><th align="center" rowspan="2" style="border-bottom: thin solid; border-color: #000000" valign="middle" colspan="1">p value</th></tr><tr style="background-color:#8FAAD8;"><th align="center" valign="middle" rowspan="1" colspan="1">OR</th><th align="center" valign="middle" rowspan="1" colspan="1">95%CI</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Prefrail<xref rid="TFN11" ref-type="table-fn">*</xref>
</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">1.41</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">0.69 - 2.90</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Frail<xref rid="TFN11" ref-type="table-fn">*</xref>
</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">1.91</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">0.93 - 3.92</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.08</td></tr><tr style="background-color:#8FAAD8;"><td align="left" colspan="4" valign="middle" rowspan="1">6-month mortality</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">ICU LOS<xref rid="TFN12" ref-type="table-fn">&#x02020;</xref>
</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">1.02</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">1.00 - 1.04</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.023</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Prefrail<xref rid="TFN11" ref-type="table-fn">*</xref>
</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">1.05</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">0.54 - 2.07</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.883</td></tr><tr><td align="left" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">Frail<xref rid="TFN11" ref-type="table-fn">*</xref>
</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">2.14</td><td align="center" style="background-color:#D5DCE4" valign="middle" rowspan="1" colspan="1">1.11 - 4.11</td><td align="center" style="background-color:#F4EFED" valign="middle" rowspan="1" colspan="1">0.023</td></tr></tbody></table><table-wrap-foot><fn id="TFN10"><p>OR - odds ratio; 95%CI - 95% confidence interval; ICU - intensive care unit; LOS - length of stay.</p></fn><fn id="TFN11"><label>*</label><p>Control: nonfrail;</p></fn><fn id="TFN12"><label>&#x02020;</label><p>By day.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In this study, we aimed to analyze the relationships between frailty and ICU, hospital, and 6-month mortality. Additionally, we explored the relationship between the ICU LOS and mortality.</p><p>Frail patients were significantly older and had higher SAPS II scores, but few differences were observed in patients who needed organ support therapies. Mortality increased with frailty, either ICU, hospital, or 6-month mortality, even after adjusting for severity scores. These differences were especially pronounced in patients with long ICU stays. In addition, the need for hospital readmission in those discharged was much more common in frail patients.</p><p>An association between frailty and hospital mortality has been reported in previous studies.<sup>(<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B9" ref-type="bibr">9</xref>)</sup> In our study, frailty was independently associated with 6-month all-cause mortality. Frailty represents a dimension of the patient evaluation that escapes from the severity scores traditionally used in the ICU; therefore, it could complement the SAPS II in assessing patient prognosis.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup></p><p>Critical illness is associated with significant disturbances in the homeostasis of each patient, persistent inflammation, and sequelae of dysfunction after hospital discharge.<sup>(<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>)</sup> Additionally, all invasive interventions during intensive care hospitalization can contribute to patient deterioration, resulting in a predictable negative long-term impact,<sup>(<xref rid="B13" ref-type="bibr">13</xref>)</sup> which is primarily time dependent.<sup>(<xref rid="B14" ref-type="bibr">14</xref>)</sup> Therefore, patients with lower functional reserves, including frail patients, are less tolerant of the persistence of the disease and prolonged hospitalization. This may even be more pronounced in critically ill septic patients.<sup>(<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>)</sup> In addition, some patients may already present an underrecognized end-of-life trajectory that becomes apparent only during their critical illness.<sup>(<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>)</sup> We have previously shown<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup> that frail patients were commonly treated with invasive organ support therapy and subsequently, provided a DNR order.</p><p>Accordingly, an interaction between LOS in the ICU and frailty could be expected. Our study revealed that frailty and longer durations in the ICU were independently associated with long-term mortality but not hospital mortality (<xref rid="t4" ref-type="table">Table 4</xref>). This finding attests to the potential interaction between frailty and a long ICU stay that influences the risk of a poor outcome.<sup>(<xref rid="B19" ref-type="bibr">19</xref>)</sup> In a recently published study of patients with an ICU LOS &#x02265; 7 days, frailty strongly influenced 6-month mortality and quality of life.<sup>(<xref rid="B19" ref-type="bibr">19</xref>)</sup> These findings align with our data and those of other previously published studies,<sup>(<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B20" ref-type="bibr">20</xref>)</sup> suggesting an independent impact of frailty on outcomes. Our study stands out for its unique analysis of the relationships among frailty, ICU LOS and mortality, revealing that this association is not as evident in patients with a short ICU stay. Not only did patients with longer ICU stays have higher 6-month mortality rates than those with shorter ICU durations, but this difference between long and short ICU LOSs was more pronounced in frail patients: OR (95% CI) for frail patients 3.1 (1.2 - 7.8) <italic toggle="yes">versus</italic> for nonfrail patients 1.8 (0.9 - 4.0).</p><p>Our study has several limitations, mostly due to its relatively small sample size, which limits our conclusions. In addition, we did not address end-of-life decisions after ICU discharge or measure quality of life after hospital discharge, which may have influenced our results.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Frailty may influence patient outcomes in the intensive care unit, including short- and long-term mortality. In our cohort, a prolonged intensive care unit length of stay was associated with a worse long-term outcome, especially in frail patients.</p></sec></body><back><fn-group><fn fn-type="other" id="fn1"><p>Publisher's note</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferrante</surname><given-names>LE</given-names></name>
<name><surname>Szczeklik</surname><given-names>W</given-names></name>
</person-group><article-title>Frailty is crucial in FORECASTing outcomes in critical care</article-title><source>Intensive Care Med</source><year>2024</year><volume>50</volume><issue>7</issue><fpage>1119</fpage><lpage>1122</lpage><pub-id pub-id-type="pmid">38953928</pub-id>
</element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Muscedere</surname><given-names>J</given-names></name>
<name><surname>Waters</surname><given-names>B</given-names></name>
<name><surname>Varambally</surname><given-names>A</given-names></name>
<name><surname>Bagshaw</surname><given-names>SM</given-names></name>
<name><surname>Boyd</surname><given-names>JG</given-names></name>
<name><surname>Maslove</surname><given-names>D</given-names></name>
<etal/>
</person-group><article-title>The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis</article-title><source>Intensive Care Med</source><year>2017</year><volume>43</volume><issue>8</issue><fpage>1105</fpage><lpage>1122</lpage><pub-id pub-id-type="pmid">28676896</pub-id>
</element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Biasio</surname><given-names>JC</given-names></name>
<name><surname>Mittel</surname><given-names>AM</given-names></name>
<name><surname>Mueller</surname><given-names>AL</given-names></name>
<name><surname>Ferrante</surname><given-names>LE</given-names></name>
<name><surname>Kim</surname><given-names>DH</given-names></name>
<name><surname>Shaefi</surname><given-names>S</given-names></name>
</person-group><article-title>Frailty in critical care medicine: a review</article-title><source>Anesth Analg</source><year>2020</year><volume>130</volume><issue>6</issue><fpage>1462</fpage><lpage>1473</lpage><pub-id pub-id-type="pmid">32384336</pub-id>
</element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bruno</surname><given-names>RR</given-names></name>
<name><surname>Wernly</surname><given-names>B</given-names></name>
<name><surname>Bagshaw</surname><given-names>SM</given-names></name>
<name><surname>van den Boogaard</surname><given-names>M</given-names></name>
<name><surname>Darvall</surname><given-names>JN</given-names></name>
<name><surname>De Geer</surname><given-names>L</given-names></name>
<etal/>
</person-group><article-title>The Clinical Frailty Scale for mortality prediction of old acutely admitted intensive care patients: a meta-analysis of individual patient-level data</article-title><source>Ann Intensive Care</source><year>2023</year><volume>13</volume><issue>1</issue><fpage>37</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">37133796</pub-id>
</element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hope</surname><given-names>AA</given-names></name>
<name><surname>Hsieh</surname><given-names>SJ</given-names></name>
<name><surname>Petti</surname><given-names>A</given-names></name>
<name><surname>Hurtado-Sbordoni</surname><given-names>M</given-names></name>
<name><surname>Verghese</surname><given-names>J</given-names></name>
<name><surname>Gong</surname><given-names>MN</given-names></name>
</person-group><article-title>Assessing the usefulness and validity of frailty markers in critically ill adults</article-title><source>Ann Am Thorac Soc</source><year>2017</year><volume>14</volume><issue>6</issue><fpage>952</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">28358584</pub-id>
</element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darvall</surname><given-names>JN</given-names></name>
<name><surname>Greentree</surname><given-names>K</given-names></name>
<name><surname>Braat</surname><given-names>MS</given-names></name>
<name><surname>Story</surname><given-names>DA</given-names></name>
<name><surname>Lim</surname><given-names>WK</given-names></name>
</person-group><article-title>Contributors to frailty in critical illness: multi-dimensional analysis of the Clinical Frailty Scale</article-title><source>J Crit Care</source><year>2019</year><volume>52</volume><fpage>193</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">31096100</pub-id>
</element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Correia</surname><given-names>I</given-names></name>
<name><surname>Simas</surname><given-names>&#x000c2;</given-names></name>
<name><surname>Chaves</surname><given-names>S</given-names></name>
<name><surname>Paix&#x000e3;o</surname><given-names>AI</given-names></name>
<name><surname>Catarino</surname><given-names>A</given-names></name>
<name><surname>Gon&#x000e7;alves-Pereira</surname><given-names>J</given-names></name>
</person-group><article-title>The PALliative MUlticenter Study in Intensive Care (PalMuSIC). Results from a multicenter study addressing frailty and palliative care interventions in intensive care units in Portugal</article-title><source>J Palliat Care</source><year>2022</year><volume>37</volume><issue>4</issue><fpage>552</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">34128431</pub-id>
</element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Graham</surname><given-names>JE</given-names></name>
<name><surname>Snih</surname><given-names>SA</given-names></name>
<name><surname>Berges</surname><given-names>IM</given-names></name>
<name><surname>Ray</surname><given-names>LA</given-names></name>
<name><surname>Markides</surname><given-names>KS</given-names></name>
<name><surname>Ottenbacher</surname><given-names>KJ</given-names></name>
</person-group><article-title>Frailty and 10-year mortality in community-living Mexican American older adults</article-title><source>Gerontology</source><year>2009</year><volume>55</volume><issue>6</issue><fpage>644</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">19690395</pub-id>
</element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ensrud</surname><given-names>KE</given-names></name>
<name><surname>Ewing</surname><given-names>SK</given-names></name>
<name><surname>Cawthon</surname><given-names>PM</given-names></name>
<name><surname>Fink</surname><given-names>HA</given-names></name>
<name><surname>Taylor</surname><given-names>BC</given-names></name>
<name><surname>Cauley</surname><given-names>JA</given-names></name>
<etal/>
<collab>Osteoporotic Fractures in Men Research Group</collab>
</person-group><article-title>A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men</article-title><source>J Am Geriatr Soc</source><year>2009</year><volume>57</volume><issue>3</issue><fpage>492</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">19245414</pub-id>
</element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Muscedere</surname><given-names>J</given-names></name>
<name><surname>Bagshaw</surname><given-names>SM</given-names></name>
<name><surname>Kho</surname><given-names>M</given-names></name>
<name><surname>Mehta</surname><given-names>S</given-names></name>
<name><surname>Cook</surname><given-names>DJ</given-names></name>
<name><surname>Boyd</surname><given-names>JG</given-names></name>
<etal/>
<collab>Canadian Critical Care Trials Group</collab>
</person-group><article-title>Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST): a prospective, multi-centre, cohort study</article-title><source>Intensive Care Med</source><year>2024</year><volume>50</volume><issue>7</issue><fpage>1064</fpage><lpage>1074</lpage><pub-id pub-id-type="pmid">38748266</pub-id>
</element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Voiriot</surname><given-names>G</given-names></name>
<name><surname>Oualha</surname><given-names>M</given-names></name>
<name><surname>Pierre</surname><given-names>A</given-names></name>
<name><surname>Salmon-Gandonni&#x000e8;re</surname><given-names>C</given-names></name>
<name><surname>Gaudet</surname><given-names>A</given-names></name>
<name><surname>Jouan</surname><given-names>Y</given-names></name>
<etal/>
<collab>la CRT de la SRLF</collab>
</person-group><article-title>Chronic critical illness and post-intensive care syndrome: from pathophysiology to clinical challenges</article-title><source>Ann Intensive Care</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>58</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">35779142</pub-id>
</element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mankowski</surname><given-names>RT</given-names></name>
<name><surname>Yende</surname><given-names>S</given-names></name>
<name><surname>Angus</surname><given-names>DC</given-names></name>
</person-group><article-title>Long-term impact of sepsis on cardiovascular health</article-title><source>Intensive Care Med</source><year>2019</year><volume>45</volume><issue>1</issue><fpage>78</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">29740669</pub-id>
</element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gritte</surname><given-names>RB</given-names></name>
<name><surname>Souza-Siqueira</surname><given-names>T</given-names></name>
<name><surname>Curi</surname><given-names>R</given-names></name>
<name><surname>Machado</surname><given-names>MC</given-names></name>
<name><surname>Soriano</surname><given-names>FG</given-names></name>
</person-group><article-title>Why septic patients remain sick after hospital discharge?</article-title><source>Front Immunol</source><year>2021</year><volume>11</volume><fpage>605666</fpage><lpage>605666</lpage><pub-id pub-id-type="pmid">33658992</pub-id>
</element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rodrigues</surname><given-names>AR</given-names></name>
<name><surname>Oliveira</surname><given-names>A</given-names></name>
<name><surname>Vieira</surname><given-names>T</given-names></name>
<name><surname>Assis</surname><given-names>R</given-names></name>
<name><surname>Lume</surname><given-names>C</given-names></name>
<name><surname>Gon&#x000e7;alves-Pereira</surname><given-names>J</given-names></name>
<etal/>
</person-group><article-title>A prolonged intensive care unit stay defines a worse long-term prognosis - Insights from the critically ill mortality by age (Cimba) study</article-title><source>Aust Crit Care</source><year>2024</year><volume>37</volume><issue>5</issue><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">38649316</pub-id>
</element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ibarz</surname><given-names>M</given-names></name>
<name><surname>Haas</surname><given-names>LE</given-names></name>
<name><surname>Ceccato</surname><given-names>A</given-names></name>
<name><surname>Artigas</surname><given-names>A</given-names></name>
</person-group><article-title>The critically ill older patient with sepsis: a narrative review</article-title><source>Ann Intensive Care</source><year>2024</year><volume>14</volume><issue>1</issue><fpage>6</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">38200360</pub-id>
</element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ge</surname><given-names>S</given-names></name>
<name><surname>Zha</surname><given-names>L</given-names></name>
<name><surname>Tanaka</surname><given-names>A</given-names></name>
<name><surname>Narii</surname><given-names>N</given-names></name>
<name><surname>Shimomura</surname><given-names>Y</given-names></name>
<name><surname>Komatsu</surname><given-names>M</given-names></name>
<etal/>
</person-group><article-title>Post-discharge functional outcomes in older patients with sepsis</article-title><source>Crit Care</source><year>2024</year><volume>28</volume><issue>1</issue><fpage>281</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">39210369</pub-id>
</element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cardona-Morrell</surname><given-names>M</given-names></name>
<name><surname>Kim</surname><given-names>J</given-names></name>
<name><surname>Turner</surname><given-names>RM</given-names></name>
<name><surname>Anstey</surname><given-names>M</given-names></name>
<name><surname>Mitchell</surname><given-names>IA</given-names></name>
<name><surname>Hillman</surname><given-names>K</given-names></name>
</person-group><article-title>Non-beneficial treatments in hospital at the end of life: a systematic review on extent of the problem</article-title><source>Int J Qual Health Care</source><year>2016</year><volume>28</volume><issue>4</issue><fpage>456</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">27353273</pub-id>
</element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hillman</surname><given-names>K</given-names></name>
</person-group><article-title>Letter to editor: Critical care beyond organ support: the importance of geriatric rehabilitation</article-title><source>Ann Intensive Care</source><year>2024</year><volume>14</volume><issue>1</issue><fpage>125</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">39158791</pub-id>
</element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wozniak</surname><given-names>H</given-names></name>
<name><surname>Beckmann</surname><given-names>TS</given-names></name>
<name><surname>Dos Santos Rocha</surname><given-names>A</given-names></name>
<name><surname>Pugin</surname><given-names>J</given-names></name>
<name><surname>Heidegger</surname><given-names>CP</given-names></name>
<name><surname>Cereghetti</surname><given-names>S</given-names></name>
</person-group><article-title>Long-stay ICU patients with frailty: mortality and recovery outcomes at 6 months</article-title><source>Ann Intensive Care</source><year>2024</year><volume>14</volume><issue>1</issue><fpage>31</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">38401034</pub-id>
</element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bagshaw</surname><given-names>SM</given-names></name>
<name><surname>Stelfox</surname><given-names>HT</given-names></name>
<name><surname>McDermid</surname><given-names>RC</given-names></name>
<name><surname>Rolfson</surname><given-names>DB</given-names></name>
<name><surname>Tsuyuki</surname><given-names>RT</given-names></name>
<name><surname>Baig</surname><given-names>N</given-names></name>
<etal/>
</person-group><article-title>Association between frailty and short- and long-term outcomes among critically ill patients: a multicentre prospective cohort study</article-title><source>CMAJ</source><year>2014</year><volume>186</volume><issue>2</issue><fpage>E95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">24277703</pub-id>
</element-citation></ref></ref-list></back></article>